NCT01865461 (HEPAT_MR) is a clinical trial in Iron and Fat Hepatic Overload, sponsored by Rennes University Hospital.

Who is sponsoring NCT01865461?

NCT01865461 is sponsored by Rennes University Hospital.

What condition does NCT01865461 study?

NCT01865461 studies Iron and Fat Hepatic Overload.

Is NCT01865461 still recruiting?

NCT01865461 is currently completed. Last updated 11 March 2021.

Last reviewed 2021-03-11 · How we verify

NCT01865461: HEPAT_MR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of MRI Sequences in Hepatic Overload

Completed Last updated 11 March 2021

What this trial tests

trial in Iron and Fat Hepatic Overload in 706 participants. Completed in 19 December 2018.

Timeline

4 March 2013

Primary endpoint
19 December 2018

19 December 2018

Quick facts

Lead sponsor	Rennes University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	706
Start date	4 March 2013
Primary completion	19 December 2018
Estimated completion	19 December 2018
Sites	1 location across France

Conditions studied

Iron and Fat Hepatic Overload — all drugs for Iron and Fat Hepatic Overload →

Sponsor

Rennes University Hospital

Who can join

18 and older, any sex, with Iron and Fat Hepatic Overload. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

MRI, without any contrast injection, allows a non-invasive evaluation and quantification of hepatic overloads, especially iron (liver iron content LIC) and fat (steatosis) overloads, but in certain clinical circumstances, cases require to improve performances. The aim of the study is to add to MRI scans which currently must be performed innovative sequences appropriate for the clinical question to overall appreciate on a varied range of patients their quality, their robustness, their relative performance and, for patients having a biopsy, their accuracy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Rennes University Hospital trials

Trials by the same sponsor.

NCT07527949 — PASTRAMI : Patient-specific Statistics for Microstructure-augmented Connectomics · NA · not yet recruiting
NCT07449832 — Sperm Epigenome in Hodgkin Lymphoma · NA · not yet recruiting
NCT06950398 — Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers · Phase 2 · not yet recruiting
NCT07188753 — Randomized Controlled Trial Testing the Efficacy of Transcranial Magnetic Stimulation by Accelerated & High-dose Theta-b · NA · not yet recruiting
NCT06898099 — Evaluation of the Efficacy of E2R Hypnotherapy in the Management of Chronic Insomnia in Primary Care (HypERR) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01865461 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rennes University Hospital
Last refreshed: 11 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01865461.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing